FFA
TMCI icon

Farther Finance Advisors’s Treace Medical Concepts TMCI Stock Holding History

Farther Finance Advisors’s Portfolio TMCI Stock Details TMCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$36K Sell
8,098
-202
-2% -$906 ﹤0.01% 3683
2026
Q2 		$33K Buy
8,300
+173
+2% +$476 ﹤0.01% 3586
2026
Q1 		$11.5K Buy
8,127
+127
+2% +$253 ﹤0.01% 4015
2025
Q4 		$19.6K Buy
8,000
+7,302
+1,046% +$31.7K ﹤0.01% 3463
2025
Q3 		$4.68K Sell
698
-4,019
-85% -$26.2K ﹤0.01% 3798
2025
Q2 		$27.7K Buy
+4,717
New +$30.7K ﹤0.01% 2470
2024
Q3 		– Sell
-176
Closed -$1.14K – 4124
2024
Q2 		$1.14K Buy
176
+97
+123% +$784 ﹤0.01% 3025
2024
Q1 		$988 Sell
79
-20
-20% -$267 ﹤0.01% 2777
2023
Q4 		$1.26K Buy
+99
New +$1K ﹤0.01% 2634

Other funds holding TMCI

MAM
Marquette Asset Management Minneapolis, Minnesota $766M AUM 16.04% 1-Year Est. Return
TWD
True Wealth Design Akron, Ohio $426M AUM 16.34% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return

Farther Finance Advisors's TMCI Position: Q3 2026 in Review

Farther Finance Advisors reduced its Treace Medical Concepts (TMCI) stake by 2.4% in Q3 2026, selling an estimated $906 and leaving 8,098 shares worth $36K. The position accounts for ﹤0.01% of the portfolio, ranked #3683.

Farther Finance Advisors first reported a position in TMCI in Q4 2023 and has held it in 9 quarters since. 4 funds tracked by Wall St. Rank hold TMCI as of Q3 2026.

  • Farther Finance Advisors held 8,098 shares of Treace Medical Concepts worth $36K as of Q3 2026.
  • Farther Finance Advisors sold 202 Treace Medical Concepts shares in Q3 2026, an estimated $906.
  • Treace Medical Concepts made up ﹤0.01% of Farther Finance Advisors's portfolio in Q3 2026, its #3683 holding.
  • Farther Finance Advisors first reported a position in Treace Medical Concepts in Q4 2023 and has held it in 9 quarters since.
  • 4 funds tracked by Wall St. Rank held Treace Medical Concepts as of Q3 2026.

Based on Farther Finance Advisors's 13F filing for Q3 2026, filed 8 Oct 2026.